Small practices and rural clinics anticipate challenges storing and administering COVID-19 vaccines.
Emergency use authorization was issued for baricitinib in combination with remdesivir for hospitalized patients with COVID-19.
There are disparities in access to the internet among those with chronic health conditions such as hypertension and diabetes.
The majority of treatment options for fibromyalgia are not supported by high-quality evidence.
Support staff in health care settings have higher COVID-19 infection rates than physicians and nurses.
Study authors conducted a systematic review to assess the use of cannabis and its impact on pain in patients with rheumatic diseases.
Between 56.7 and 74.3 million US adults are at increased risk for severe COVID-19 and are either themselves an essential worker or live with one.
The mRNA-based vaccine candidate, BNT162b2, has been shown to be more than 90% effective in preventing COVID-19.
Deprescribing is necessary in a healthcare environment where patients are managed by multiple providers and take multiple medications.
The FDA approved Olinvyk for acute pain severe enough to require an IV opioid analgesic and for whom alternative treatments are inadequate.